Clinical Trials Directory

Trials / Completed

CompletedNCT01060020

Acute Hemodynamic Effects of Sildenafil in Patients With Severe Aortic Stenosis

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Washington University School of Medicine · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Pulmonary hypertension is common in patients with aortic stenosis and is associated with worse operative and long-term outcomes. Sildenafil has been shown to reduce pulmonary artery pressure and improve exercise performance in patients with left-sided heart failure, but this has not been tested in patients with aortic stenosis. We hypothesize that Sildenafil will produce a clinically significant decrease in pulmonary artery pressure in patients with severe aortic stenosis. The dose of Sildenafil that produces a significant decrease in pulmonary artery pressure will be safe and well tolerated in patients with and without a depressed ejection fraction.

Detailed description

Patients with severe aortic stenosis referred for a clinically ordered right and left heart catheterization will be eligible. Twenty subjects will be enrolled: 10 patients will receive 40mg and 10 patients will receive 80mg; each dose will be equally distributed among those with preserved (≥50%) and reduced (\<50%) EF. Subjects will get a baseline echo prior to the heart catheterization. Baseline invasive hemodynamic measurements will be performed using a Swan Ganz catheter. A single oral dose of sildenafil will then be administered (40mg or 80mg), followed by invasive hemodynamic measurements at 30 and 60 minutes. Also at 60 minutes, limited echocardiographic images will be obtained.

Conditions

Interventions

TypeNameDescription
DRUGSildenafilSingle oral dose of 40mg or 80mg of Sildenafil

Timeline

Start date
2010-01-01
Primary completion
2011-09-01
Completion
2011-10-01
First posted
2010-02-01
Last updated
2018-04-25
Results posted
2018-04-25

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01060020. Inclusion in this directory is not an endorsement.